Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Don't Miss Gains in MRK, XOM, JNJ and PFE

Marketwired April 5, 2013

Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations

Marketwired April 4, 2013

Sizzling Buzzers: Huntsman Corporation, Pfizer Inc, Chesapeake Energy Corporation

Accesswire April 4, 2013

The Straight Truth, Investing in PFE, AMZN and OXY

Marketwired April 4, 2013

Advil® Launches Advil® Relief in Action Campaign Celebrating Active Volunteers Who Don't Let Pain Hold Them Back

Business Wire April 4, 2013

Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures

PR Newswire April 4, 2013

Free Research Reports on D, PFE, SWY and VZ Issued by the Bedford Report

Marketwired April 4, 2013

The Straight Truth, Investing in PFE, NOK and JPM

Marketwired April 3, 2013

Before the Crowd, How We Found PFE, V, HUM and UNH

Marketwired April 2, 2013

Strategy Behind Our Success, We Get in Early: JNJ, XOM, EBAY and PFE

Marketwired April 1, 2013

S&P 500 Reaches a New All-Time High -- Index Finally Recovers From the Financial Crisis

Marketwired March 29, 2013

Pfizer's BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission

Business Wire March 28, 2013

Before the Crowd, How We Found GOOG, JNJ and PFE

Marketwired March 27, 2013

Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts

Business Wire March 26, 2013

Special Offer for Shareholders of PFE, ALU, YHOO and F

Marketwired March 26, 2013

Lpath Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP

Marketwired March 22, 2013

Perfect Trade Setups, How to Play GE, PFE, CAT and QCOM

Marketwired March 22, 2013

The Real Story Behind CAH, PFE and EBAY

Marketwired March 21, 2013

UPLYSO(TM) (alfataliglicerase) Approved in Brazil by ANVISA for the Treatment of Gaucher Disease

Troy Schwensen March 18, 2013

Daily Analysis on Active Stocks: (NYSE: PFE), (NASDAQ: MSFT)

Accesswire March 18, 2013